2A4D Argyris, Elias - Thomas Jefferson University - Thomas Jefferson University

Elias Argyris, PhD

Contact Dr. Argyris

900 Walnut Street
Philadelphia, PA 19107

(215) 503-1257
(215) 923-1956 fax

Most Recent Peer-reviewed Publications

  1. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system
  2. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4 + T lymphocytes
  3. Analysis of the CD2 and spliceosomal Sm B/B′ polyproline-arginine motifs defined by a monoclonal antibody using a phage-displayed random peptide library
  4. Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: Potential for development of lentivirucides
  5. Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines
  6. Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells
  7. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART
  8. The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity
  9. HIV-1 Vif versus APOBEC3G: Newly appreciated warriors in the ancient battle between virus and host
  10. The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity
  11. Human Immunodeficiency Virus Type 1 Enters Primary Human Brain Microvascular Endothelial Cells by a Mechanism Involving Cell Surface Proteoglycans Independent of Lipid Rafts
  12. Human leukocyte antigen Class II amino acid epitopes susceptibility and progression markers for beryllium hypersensitivity
  13. Mutagenesis of key residues identifies the connection subdomain of HIV-1 reverse transcriptase as the site of inhibition by heme
  14. The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase
  15. Identification of DRB1 allele (DRB1*1316) with aspartate at position 86: Evolutionary considerations and functional implications
  16. Genetic markers in beryllium hypersensitivity
  17. New DRB1(*)1120 allele; another example of the transition between the DR11 and DR13 families of alleles
  18. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris
  19. Employment of random peptide libraries for the identification of peptide motifs and peptides bound to diabetogenic HLA-DQ molecules
  20. Identification of HLA-DRB1*1114 by oligonucleotide typing and DNA sequencing